Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma.
Ontology highlight
ABSTRACT: Glioma is a common intracranial tumor and is generally associated with poor prognosis. Recently, numerous studies illustrated the importance of 5-methylcytosine (m5C) RNA modification to tumorigenesis. However, the prognostic value and immune correlation of m5C in glioma remain unclear. We obtained RNA expression and clinical information from The Cancer Genome Atlas (TCGA) and The Chinese Glioma Genome Atlas (CGGA) datasets to analyze. Nonnegative matrix factorization (NMF) was used to classify patients into two subgroups and compare these patients in survival and clinicopathological characteristics. CIBERSORT and single-sample gene-set algorithm (ssGSEA) methods were used to investigate the relationship between m5C and the immune environment. The Weighted correlation network analysis (WGC
SUBMITTER: Xiao Z
PROVIDER: S-EPMC10683591 | biostudies-literature | 2023 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA